TPX2 and cancer: Consistent with its relevance in spindle MT nucleation and organisation, and with results previously obtained in cancer cells, TPX2 overexpression yields MT organisation defects, associated with prolonged mitosis, and hyperstable MTs that are more resistant to nocodazole treatment or ice-induced depolymerisation compared with control cells [51,88].